Varian Medical Systems, Inc. (NYSE:VAR) SVP John W. Kuo sold 6,442 shares of the company’s stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $120.67, for a total transaction of $777,356.14. Following the sale, the senior vice president now directly owns 28,224 shares in the company, valued at approximately $3,405,790.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Varian Medical Systems, Inc. (VAR) opened at $121.26 on Monday. Varian Medical Systems, Inc. has a 12 month low of $81.55 and a 12 month high of $130.29. The firm has a market cap of $11,090.00, a price-to-earnings ratio of 87.24, a PEG ratio of 3.52 and a beta of 0.81.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The business had revenue of $678.50 million for the quarter, compared to the consensus estimate of $633.96 million. During the same quarter in the prior year, the firm posted $1.09 earnings per share. The business’s revenue for the quarter was up 12.8% on a year-over-year basis. analysts anticipate that Varian Medical Systems, Inc. will post 4.31 earnings per share for the current fiscal year.
A number of equities research analysts recently issued reports on VAR shares. Zacks Investment Research downgraded shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Royal Bank of Canada set a $105.00 price target on shares of Varian Medical Systems and gave the company a “hold” rating in a research note on Thursday, November 30th. TheStreet downgraded shares of Varian Medical Systems from a “b+” rating to a “c” rating in a research note on Monday, February 12th. Evercore ISI started coverage on shares of Varian Medical Systems in a research note on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price target on the stock. Finally, Citigroup upped their price target on shares of Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $108.44.
TRADEMARK VIOLATION WARNING: “Insider Selling: Varian Medical Systems, Inc. (VAR) SVP Sells 6,442 Shares of Stock” was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://stocknewstimes.com/2018/02/19/insider-selling-varian-medical-systems-inc-var-svp-sells-6442-shares-of-stock.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.